Clinical vignette in antiretroviral therapy: rash illness.
This clinical vignette focuses on intercurrent illness following antiretroviral therapy and unexplained rash. It uses tables to identify specific highly active antiretroviral therapy (HAART)-related adverse events, and to assist clinicians in interpreting cutaneous clinical findings in physiologic terms.
Zell
Steven C
SC
Department of Internal Medicine and Health Care Research, University of Nevada School of Medicine, Reno, Nevada, USA. sczell@unr.edu
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D003937:Diagnosis, Differential; D015224:Dideoxynucleosides / Q000009:adverse effects; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy; D005076:Exanthema / Q000139:chemically induced; D005938:Glucocorticoids / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D000099227:Abacavir
D015224:Dideoxynucleosides; D005938:Glucocorticoids; D019829:Nevirapine; D011241:Prednisone; D000099227:Abacavir